118 related articles for article (PubMed ID: 15975018)
21. CD8 T-cell memory differentiation during acute and chronic viral infections.
Kalia V; Sarkar S; Ahmed R
Adv Exp Med Biol; 2010; 684():79-95. PubMed ID: 20795542
[TBL] [Abstract][Full Text] [Related]
22. Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis.
Hovav AH; Cayabyab MJ; Panas MW; Santra S; Greenland J; Geiben R; Haynes BF; Jacobs WR; Letvin NL
J Virol; 2007 Jan; 81(1):74-83. PubMed ID: 17050608
[TBL] [Abstract][Full Text] [Related]
23. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
Gómez CE; Abaitua F; Rodríguez D; Esteban M
Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination.
Freel SA; Lamoreaux L; Chattopadhyay PK; Saunders K; Zarkowsky D; Overman RG; Ochsenbauer C; Edmonds TG; Kappes JC; Cunningham CK; Denny TN; Weinhold KJ; Ferrari G; Haynes BF; Koup RA; Graham BS; Roederer M; Tomaras GD
J Virol; 2010 May; 84(10):4998-5006. PubMed ID: 20200250
[TBL] [Abstract][Full Text] [Related]
25. Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.
Wang X; Uto T; Akagi T; Akashi M; Baba M
J Virol; 2007 Sep; 81(18):10009-16. PubMed ID: 17609261
[TBL] [Abstract][Full Text] [Related]
26. Peptide-MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development.
Reguzova AY; Karpenko LI; Mechetina LV; Belyakov IM
Expert Rev Vaccines; 2015 Jan; 14(1):69-84. PubMed ID: 25373312
[TBL] [Abstract][Full Text] [Related]
27. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
[TBL] [Abstract][Full Text] [Related]
28. CD8(+) T cells in preventing HIV infection and disease.
McDermott AB; Koup RA
AIDS; 2012 Jun; 26(10):1281-92. PubMed ID: 22441256
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells.
Zajac AJ; Murali-Krishna K; Blattman JN; Ahmed R
Curr Opin Immunol; 1998 Aug; 10(4):444-9. PubMed ID: 9722921
[TBL] [Abstract][Full Text] [Related]
30. Skin vaccination with live virus vectored microneedle arrays induce long lived CD8(+) T cell memory.
Becker PD; Hervouet C; Mason GM; Kwon SY; Klavinskis LS
Vaccine; 2015 Sep; 33(37):4691-8. PubMed ID: 25917679
[TBL] [Abstract][Full Text] [Related]
31. The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?
McMichael A; Hanke T
Nat Rev Immunol; 2002 Apr; 2(4):283-91. PubMed ID: 12001999
[TBL] [Abstract][Full Text] [Related]
32. Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.
Hopkins R; Bridgeman A; Bourne C; Mbewe-Mvula A; Sadoff JC; Both GW; Joseph J; Fulkerson J; Hanke T
Eur J Immunol; 2011 Dec; 41(12):3542-52. PubMed ID: 21932450
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines.
Belyakov IM; Ahlers JD
Curr Med Chem; 2011; 18(26):3953-62. PubMed ID: 21824096
[TBL] [Abstract][Full Text] [Related]
34. Virus-specific CD8 T cells: activation, differentiation and memory formation.
Wiesel M; Walton S; Richter K; Oxenius A
APMIS; 2009 May; 117(5-6):356-81. PubMed ID: 19400862
[TBL] [Abstract][Full Text] [Related]
35. CD8
Wu X; Wu P; Shen Y; Jiang X; Xu F
Front Immunol; 2018; 9():2093. PubMed ID: 30283442
[TBL] [Abstract][Full Text] [Related]
36. Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years.
Lind A; Sommerfelt M; Holmberg JO; Baksaas I; Sørensen B; Kvale D
Scand J Infect Dis; 2012 Aug; 44(8):566-72. PubMed ID: 22339485
[TBL] [Abstract][Full Text] [Related]
37. Balance between activation and regulation of HIV-specific CD8+ T-cell response after modified vaccinia Ankara B therapeutic vaccination.
Rallón N; Mothe B; Lopez Bernaldo de Quiros JC; Plana M; Ligos JM; Montoya M; Muñoz-Fernández MA; Esteban M; Garcia F; Brander C; Benito JM;
AIDS; 2016 Feb; 30(4):553-62. PubMed ID: 26558724
[TBL] [Abstract][Full Text] [Related]
38. Understanding the mechanisms and limitations of immune control of HIV.
Davenport MP; Ribeiro RM; Zhang L; Wilson DP; Perelson AS
Immunol Rev; 2007 Apr; 216():164-75. PubMed ID: 17367342
[TBL] [Abstract][Full Text] [Related]
39. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic and functional analysis of immune CD8+ T cell responses induced by a single injection of a HIV DNA vaccine in mice.
Arrode G; Hegde R; Mani A; Jin Y; Chebloune Y; Narayan O
J Immunol; 2007 Feb; 178(4):2318-27. PubMed ID: 17277137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
